Charles Douglas Blundell
Gründer bei C4X Discovery Ltd.
Profil
Charles Douglas Blundell is the founder.
He founded C4X Discovery Ltd.
in 2008 and currently holds the title of Director & Chief Scientific Officer.
He also founded C4X Discovery Holdings Plc in 2008 and held the title of Chief Scientific Officer.
Dr. Blundell obtained a doctorate degree from the University of Oxford.
Aktive Positionen von Charles Douglas Blundell
Unternehmen | Position | Beginn |
---|---|---|
C4X Discovery Ltd.
C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Gründer | 23.11.2009 |
Ehemalige bekannte Positionen von Charles Douglas Blundell
Unternehmen | Position | Ende |
---|---|---|
C4X DISCOVERY HOLDINGS PLC | Gründer | - |
Ausbildung von Charles Douglas Blundell
University of Oxford | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
C4X DISCOVERY HOLDINGS PLC | Health Technology |
Private Unternehmen | 1 |
---|---|
C4X Discovery Ltd.
C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Health Technology |